These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19669189)

  • 21. Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma.
    Yoshino T; Tanaka T; Sato Y
    J Clin Exp Hematop; 2020 Dec; 60(4):124-129. PubMed ID: 32249238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists.
    Pathol Int; 2000 Sep; 50(9):696-702. PubMed ID: 11012982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
    White WL; Ferry JA; Harris NL; Grove AS
    Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoma classification update: B-cell non-Hodgkin lymphomas.
    Jiang M; Bennani NN; Feldman AL
    Expert Rev Hematol; 2017 May; 10(5):405-415. PubMed ID: 28395545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
    Patel N; Durkin L; Bodo J; Hsi ED
    Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology of indolent B-cell neoplasms other than follicular lymphoma.
    Sakata S; Tsuyama N; Takeuchi K
    J Clin Exp Hematop; 2014; 54(1):11-22. PubMed ID: 24942942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases.
    Andriko JA; Swerdlow SH; Aguilera NI; Abbondanzo SL
    Am J Surg Pathol; 2001 Jun; 25(6):742-51. PubMed ID: 11395551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Hodgkin's lymphoproliferative disorders involving the spleen.
    Arber DA; Rappaport H; Weiss LM
    Mod Pathol; 1997 Jan; 10(1):18-32. PubMed ID: 9021723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic lymphoid leukemias: recent advances in biology and therapy.
    Foon KA
    Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features of splenic tumours of lymphoid tissue.
    Chen DB; Shen DH; Yang SM; Fang XZ
    Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition):lymphoid tumors].
    Polyatskin IL; Artemyeva AS; Krivolapov YA
    Arkh Patol; 2019; 81(3):59-65. PubMed ID: 31317932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Revised European-American Classification of Lymphoid Neoplasms (REAL): a new perspective for the classification of cutaneous lymphomas.
    Sander CA; Kind P; Kaudewitz P; Raffeld M; Jaffe ES
    J Cutan Pathol; 1997 Jul; 24(6):329-41. PubMed ID: 9243360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
    Ohshima K; Suzumiya J; Kikuchi M
    Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.
    Turner JJ; Morton LM; Linet MS; Clarke CA; Kadin ME; Vajdic CM; Monnereau A; Maynadié M; Chiu BC; Marcos-Gragera R; Costantini AS; Cerhan JR; Weisenburger DD
    Blood; 2010 Nov; 116(20):e90-8. PubMed ID: 20699439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffuse large B-cell lymphoma--more than a diffuse collection of large B cells: an entity in search of a meaningful classification.
    Gurbuxani S; Anastasi J; Hyjek E
    Arch Pathol Lab Med; 2009 Jul; 133(7):1121-34. PubMed ID: 19642739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Overview of 2008 WHO Classification of Malignant Lymphoma].
    Nakamura S
    Rinsho Byori; 2010 Nov; 58(11):1105-11. PubMed ID: 21229709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology.
    Carbone A; Gloghini A; Aiello A; Testi A; Cabras A
    Hum Pathol; 2010 May; 41(5):621-31. PubMed ID: 20398809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.
    Grimm KE; O'Malley DP
    Ann Diagn Pathol; 2019 Feb; 38():6-10. PubMed ID: 30380402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.